Vascular response to coronary artery stenting in mature and juvenile swine

Cardiovascular Revascularization Medicine

Volumn 12, Issue 6, 2011, Pages 375-384

  Sheehy, Alexander ^a   Hsu, Steve ^a   Sinn, Irene ^a   Tai, Julie ^a   Kolodgie, Frank D ^b   Nakazawa, Gaku ^b   Yazdani, Saami K ^b   Quee, Shawn Chin ^a   Virmani, Renu ^b   Polyakov, Igor ^a  

^a ABBOTT VASCULAR   (United States)

^b CVPATH INSTITUTE   (United States)

Author keywords

Aging; Coronary stenting; Inflammation; Swine

Indexed keywords

ACETYLSALICYLIC ACID; CD40 ANTIGEN; CLOPIDOGREL; EVEROLIMUS; FIBRIN; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULAR CELL ADHESION MOLECULE 1;

ADOLESCENT; AGE DISTRIBUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BARE METAL STENT; BLOOD VESSEL; BLOOD VESSEL REACTIVITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DRUG ELUTING STENT; ENDOTHELIUM CELL; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IMPLANTATION; INFLAMMATION; JUVENILE; LOADING DRUG DOSE; MICROSCOPY; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; STUDENT T TEST; SWINE;

AGE FACTORS; ANALYSIS OF VARIANCE; ANGIOPLASTY, BALLOON, CORONARY; ANIMALS; CELL PROLIFERATION; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY VESSELS; DRUG-ELUTING STENTS; FOREIGN-BODY REACTION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; METALS; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, SCANNING; MODELS, ANIMAL; PROSTHESIS DESIGN; RNA, MESSENGER; STENTS; SWINE; TIME FACTORS;

EID: 82755189956     PISSN: 15538389     EISSN: 18780938     Source Type: Journal    
DOI: 10.1016/j.carrev.2011.05.003     Document Type: Article

References (39)

1. Lowe HC, Schwartz RS, Mac Neill BD, Jang IK, Hayase M, Rogers C, Oesterle SN The porcine coronary model of in-stent restenosis: current status in the era of drug-eluting stents. Catheter Cardiovasc Interv 2003, 60:515-523.
2. Guidance for Industry Coronary drug-eluting stents - nonclinical and clinical studies. Draft guidance 2008, 333. http://www.fda.gov/cder/guidance/index.htm.
3. Virmani R, Farb A, Kolodgie FD Histopathologic alterations after endovascular radiation and antiproliferative stents: similarities and differences. Herz 2002, 27:1-6.
4. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002, 346:1773-1780.
5. Torella D, Leosco D, Indolfi C, Curcio A, Coppola C, Ellison GM, Russo VG, Torella M, Li Volti G, Rengo F, Chiariello M Aging exacerbates negative remodeling and impairs endothelial regeneration after balloon injury. Am J Physiol Heart Circ Physiol 2004, 287:H2850-H2860.
6. Lakatta EG Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part III: cellular and molecular clues to heart and arterial aging. Circulation 2003, 107:490-497.
7. Stone GW, Rizvi A, Newman W, Mastali K, Wang JC, Caputo R, Doostzadeh J, Cao S, Simonton CA, Sudhir K, Lansky AJ, Cutlip DE, Kereiakes DJ Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. N Engl J Med 2010, 362:1663-1674.
8. Schwartz RS, Edelman E, Virmani R, Carter A, Granada JF, Kaluza GL, Chronos NA, Robinson KA, Waksman R, Weinberger J, Wilson GJ, Wilensky RL Drug-eluting stents in preclinical studies: updated consensus recommendations for preclinical evaluation. Circ Cardiovasc Interv 2008, 1:143-153.
9. Finn AV, Kolodgie FD, Harnek J, Guerrero LJ, Acampado E, Tefera K, Skorija K, Weber DK, Gold HK, Virmani R Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 2005, 112:270-278.
10. Piali L, Hammel P, Uherek C, Bachmann F, Gisler RH, Dunon D, Imhof BA CD31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion of leukocytes to endothelium. J Cell Biol 1995, 130:451-460.
11. Cybulsky MI, Gimbrone MA Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991, 251:788-791.
12. Sriramarao P, Languino LR, Altieri DC Fibrinogen mediates leukocyte-endothelium bridging in vivo at low shear forces. Blood 1996, 88:3416-3423.
13. Rollins BJ, Yoshimura T, Leonard EJ, Pober JS Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. Am J Pathol 1990, 136:1229-1233.
14. Hollenbaugh D, Mischel-Petty N, Edwards CP, Simon JC, Denfeld RW, Kiener PA, Aruffo A Expression of functional CD40 by vascular endothelial cells. J Exp Med 1995, 182:33-40.
15. Newton JP, Buckley CD, Jones EY, Simmons DL Residues on both faces of the first immunoglobulin fold contribute to homophilic binding sites of PECAM-1/CD31. J Biol Chem 1997, 272:20555-20563.
16. Ali J, Liao F, Martens E, Muller WA Vascular endothelial cadherin (VE-cadherin): cloning and role in endothelial cell-cell adhesion. Microcirculation 1997, 4:267-277.
17. Nourse MB, Halpin DE, Scatena M, Mortisen DJ, Tulloch NL, Hauch KD, Torok-Storb B, Ratner BD, Pabon L, Murry CE VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineering. Arterioscler Thromb Vasc Biol 2010, 30:80-89.
18. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988, 332:411-415.
19. Dai Q, Thompson MA, Pippen AM, Cherwek H, Taylor DA, Annex BH Alterations in endothelial cell proliferation and apoptosis contribute to vascular remodeling following hind-limb ischemia in rabbits. Vasc Med 2002, 7:87-91.
20. Warrior U, Fan Y, David CA, Wilkins JA, McKeegan EM, Kofron JL, Burns DJ Application of QuantiGene nucleic acid quantification technology for high throughput screening. J Biomol Screen 2000, 5:343-352.
21. Herman IM Actin isoforms. Curr Opin Cell Biol 1993, 5:48-55.
22. Kwon MJ, Oh E, Lee S, Roh MR, Kim SE, Lee Y, Choi YL, In YH, Park T, Koh SS, Shin YK Identification of novel reference genes using multiplatform expression data and their validation for quantitative gene expression analysis. PLoS One 2009, 4:e6162.
23. Schneider JE, Berk BC, Gravanis MB, Santoian EC, Cipolla GD, Tarazona N, Lassegue B, King SB Probucol decreases neointimal formation in a swine model of coronary artery balloon injury. A possible role for antioxidants in restenosis. Circulation 1993, 88:628-637.
24. Rossi GB, Mancini M, Oriente P, Vecchione A, Vecchione R, Cerqua R, Cuzzupoli M Comparative studies on serum lipids and histochemical features of the arterial wall in animal species differently susceptible to experimental atherosclerosis. J Atheroscler Res 1965, 5:569-579.
25. Sanborn TA, Haudenschild CC, Garber GR, Ryan TJ, Faxon DP Angiographic and histologic consequences of laser thermal angioplasty: comparison with balloon angioplasty. Circulation 1987, 75:1281-1286.
26. Miller RA, Wilson RB Atherosclerosis and myocardial ischemic lesions in alloxan-diabetic rabbits fed a low cholesterol diet. Arteriosclerosis 1984, 4:586-591.
27. Dixon JL, Stoops JD, Parker JL, Laughlin MH, Weisman GA, Sturek M Dyslipidemia and vascular dysfunction in diabetic pigs fed an atherogenic diet. Arterioscler Thromb Vasc Biol 1999, 19:2981-2992.
28. Hariri RJ, Alonso DR, Hajjar DP, Coletti D, Weksler ME Aging and arteriosclerosis. I. Development of myointimal hyperplasia after endothelial injury. J Exp Med 1986, 164:1171-1178.
29. Nomellini V, Faunce DE, Gomez CR, Kovacs EJ An age-associated increase in pulmonary inflammation after burn injury is abrogated by CXCR2 inhibition. J Leukoc Biol 2008, 83:1493-1501.
30. Saito H, Papaconstantinou J Age-associated differences in cardiovascular inflammatory gene induction during endotoxic stress. J Biol Chem 2001, 276:29307-29312.
31. Csiszar A, Ungvari Z, Koller A, Edwards JG, Kaley G Aging-induced proinflammatory shift in cytokine expression profile in coronary arteries. Faseb J 2003, 17:1183-1185.
32. Liu P, Xu B, Cavalieri TA, Hock CE Age-related difference in myocardial function and inflammation in a rat model of myocardial ischemia-reperfusion. Cardiovasc Res 2002, 56:443-453.
33. Welt FG, Rogers C Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol 2002, 22:1769-1776.
34. Silva GV, Fernandes MR, Madonna R, Clubb F, Oliveira E, Jimenez-Quevedo P, Branco R, Lopez J, Angeli FS, Sanz-Ruiz R, Vaughn WK, Zheng Y, Baimbridge F, Canales J, Cardoso CO, Assad JA, Falotico R, Perin EC Comparative healing response after sirolimus- and paclitaxel-eluting stent implantation in a pig model of restenosis. Catheter Cardiovasc Interv 2009, 73:801-808.
35. Li JJ, Li J, Nan JL, Li Z, Zhen X, Mu CW, Dai J, Zhang CY Coronary restenotic reduction of drug-eluting stenting may be due to its anti-inflammatory effects. Med Hypotheses 2007, 69:1004-1009.
36. Versaci F, Gaspardone A Prevention of restenosis after stenting: the emerging role of inflammation. Coron Artery Dis 2004, 15:307-311.
37. Nakazawa G, Finn AV, Joner M, Ladich E, Kutys R, Mont EK, Gold HK, Burke AP, Kolodgie FD, Virmani R Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation 2008, 118:1138-1145.
38. Joner M, Nakazawa G, Finn AV, Quee SC, Coleman L, Acampado E, Wilson PS, Skorija K, Cheng Q, Xu X, Gold HK, Kolodgie FD, Virmani R Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol 2008, 52:333-342.
39. Hall PA, Levison DA, Woods AL, Yu CC, Kellock DB, Watkins JA, Barnes DM, Gillett CE, Camplejohn R, Dover R, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990, 162:285-294.